Check Your Eligibility
Answer a few questions to see if you may qualify for this trial.
Step 1 of 8
Do you have the HLA-A*02:01 genetic marker?
This is a genetic test that identifies a specific immune marker. If you have this marker, you must have already been treated with a specific drug called tebentafusp before joining this trial. This helps us understand your treatment history and whether you're eligible.
Show original medical criteria
HLA-A*02:01 positive patients must have received tebentafusp as prior immunotherapy treatment
This is informational only — not medical advice. Always discuss eligibility with your oncologist.